The Plasmodium liver stage represents a vulnerable therapeutic target to prevent disease
progression as the parasite resides in the liver before clinical representation caused by …

Malaria causes high levels of morbidity and mortality in human beings worldwide. According
to the World Health Organization (WHO), about half a million people die of this disease each …

A reduction in the global burden of malaria over the past two decades has encouraged
efforts for regional malaria elimination. Despite the need to target all Plasmodium species …

Background. Seasonal increases in malaria continue in hot spots in Zanzibar. Mass
screening and treatment (MSAT) may help reduce the reservoir of infection; however, it is …

Abstract Background. As Indonesia works toward the goal of malaria elimination, information
is lacking on malaria epidemiology from some western provinces. As a basis for studies of …

Background The efficacy of artemisinin-based combination therapy (ACT) for Plasmodium
falciparum malaria may be threatened by parasites with reduced responsiveness to …

Background. Parasite clearance time after artemisinin-based combination therapy (ACT)
may be increasing in Asian and African settings. The association between parasite …

Malaria caused by Plasmodium ovale species is considered a neglected tropical disease
with limited information about its characteristics. It also remains unclear whether the two …

Background The epidemiology and severity of non-falciparum malaria in endemic settings
has garnered little attention. We aimed to characterise the prevalence, interaction, clinical …

Malaria in humans is caused by six species of Plasmodium parasites, of which the nuclear
genome sequences for the two Plasmodium ovale spp., P. ovale curtisi and P. ovale …